HMGCR and cancer: Notably, HMGCR inhibitors, such as statins, have been shown to significantly reduce mortality rates and extend survival periods in cancer patients, rendering them the most commonly employed drugs in clinical investigations targeting cholesterol metabolism in cancer patients.28